Bioanalysis Zone – Lisa Sellers talks opportunities, mentorship and initiatives for women in STEM
Lisa Sellers is a seasoned leader and mentor in the life sciences industry, boasting over 2 decades of experience…
Insights from our team
Vector Laboratories' blog provides a wealth of information on immunohistochemistry (IHC), immunofluorescence (IF), and related life science research topics.
Vector Laboratories, Navinci Diagnostics Partner to Develop Biomarker Discovery Tools
NEW YORK — Vector Laboratories said Tuesday that it has partnered with Swedish life science…
Vector Laboratories and Navinci Diagnostics Announce Strategic Collaboration to Develop Novel Spatial Proteomic Tools Enabling Biomarker Discovery
Introducing innovative tools combining proteomics and glycomics within the spatial context, overcoming previous challenges and advancing the possibilities for biopharma discovery. NEWARK, Calif.January 30, 2024 Vector Laboratories, the pioneer of innovative proteomic and glycomic research... Read more
It Takes Two to Tango, Part 1: Bioconjugation
In the first of our three part series on Bioconjugation, we’ll be exploring what’s involved, how it enables life science research, the challenges associated with it, and the excitement in future work.
It Takes Two to Tango, Part 2: Applications of Bioconjugation
In the previous section, we discussed the methods of bioconjugation. And the marriage of a biomolecule and a small molecule has given rise to various modalities commonly used in biomedical research. Here, we focus on... Read more
It Takes Two to Tango, Part 3: Advantages of Bioconjugation
With knowledge of the applications that bioconjugation can play into, we finish by highlighting its key advantages and critical uses. While the applications are much broader than what we summarize here, we can deduce common... Read more
The right tool for the job: selecting appropriate protein detection and visualization methods
More than 80 years later, methods to detect and visualize proteins in biological samples continue to advance, driving the discovery and development of novel therapies and diagnostics. New capabilities empower researchers to gain deep, high-resolution... Read more
Scrip Asks…What Does 2024 Hold For Biopharma? Part 2: The Funding Environment, M&A And Partnering
Since biotech valuations on public markets peaked in September 2021, the sector has had to contend with reduced financing availability and harsher conditions for deal-making.
SugarGPT: Envisioning the Future of Glycoinformatics
The body’s autoimmune response has been leveraged by cancer researchers to propel immunotherapy tools into clinical use. Although the main focus has been on the ability of T-cells to fight cancer cells, the involvement of... Read more
The value and versatility of bioconjugation
The ability to combine the activity of a biomolecule with the activity of another entity through bioconjugation has been critical to basic research and discovery for decades.
